BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn Phase 3b ALS Clinical Trials (PRNewswire) - May 27, 2025 - "BrainStorm Cell Therapeutics Inc...today announced that it has signed a Letter of Intent (LOI) with Minaris Advanced Therapies, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, to manufacture NurOwn for its upcoming clinical trial....This partnership enhances BrainStorm's U.S. based manufacturing capabilities and supports its multicenter Phase 3b clinical trial in the United States."
Commercial • Amyotrophic Lateral Sclerosis
|